Edition:
India

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

6.25USD
1:30am IST
Change (% chg)

$0.15 (+2.46%)
Prev Close
$6.10
Open
$6.15
Day's High
$6.25
Day's Low
$6.07
Volume
239,347
Avg. Vol
758,803
52-wk High
$10.65
52-wk Low
$1.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.16 December 27 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 2 5.10 7.70 2.50 --
Quarter Ending Sep-18 2 5.90 7.80 4.00 --
Year Ending Dec-18 2 20.05 31.10 9.00 13.32
Year Ending Dec-19 2 50.21 62.20 38.22 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.16 -0.15 -0.16 --
Quarter Ending Sep-18 2 -0.15 -0.15 -0.15 --
Year Ending Dec-18 2 -0.64 -0.61 -0.67 -1.48
Year Ending Dec-19 2 -0.49 -0.35 -0.63 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 12.73 20.41 7.67 60.28
Quarter Ending Sep-17 4.25 121.91 117.66 2,768.47
Quarter Ending Jun-17 4.34 4.66 0.33 7.51
Quarter Ending Mar-17 4.02 4.87 0.86 21.27
Quarter Ending Dec-16 2.99 4.02 1.03 34.37

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5.10 5.10 5.40 5.65 --
Quarter Ending Sep-18 5.90 5.90 6.00 6.65 --
Year Ending Dec-18 20.05 20.05 24.15 25.36 13.32
Year Ending Dec-19 50.21 50.21 57.80 54.90 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 1 1
Quarter Ending Sep-18 0 0 1 1
Year Ending Dec-18 0 0 1 1
Year Ending Dec-19 0 0 1 0
Earnings